Literature DB >> 11698099

Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

E Kostenis1.   

Abstract

Identification of natural ligands for orphan G-protein-coupled receptors will help expand the boundaries of physiology and pharmacology. Powerful approaches are needed that can pair biologically active ligands with their corresponding receptors. Many attempts have been made to set up universal screening schemes such that receptor activation by its cognate ligand is transduced into a common intracellular signal that is amenable to high-throughput screening analysis. One possibility that achieves such a 'universal assay' takes advantage of the promiscuous nature of the G-protein subunit Galpha16. However, a truly critical look at Galpha16 is still required. In this article, the strengths, weaknesses, problems and pitfalls that are associated with the use of Galpha16 will be discussed, and suggestions of how problems might be overcome with an optimized universal G-protein system will be proposed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698099     DOI: 10.1016/s0165-6147(00)01810-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  41 in total

Review 1.  Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Authors:  Steven J Charlton; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.

Authors:  Morgan Le Naour; Mary M Lunzer; Mike D Powers; Philip S Portoghese
Journal:  J Med Chem       Date:  2012-01-05       Impact factor: 7.446

3.  Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.

Authors:  P C Rummel; K N Arfelt; L Baumann; T J Jenkins; S Thiele; H R Lüttichau; A Johnsen; J Pease; S Ghosh; R Kolbeck; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes.

Authors:  Luis E Gimenez; Stefanie Babilon; Lizzy Wanka; Annette G Beck-Sickinger; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

5.  A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.

Authors:  Maria Waldhoer; Jamie Fong; Robert M Jones; Mary M Lunzer; Shiv K Sharma; Evi Kostenis; Philip S Portoghese; Jennifer L Whistler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

Review 6.  In vitro models: research in physiology and pharmacology of the lower urinary tract.

Authors:  Robert B Moreland
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

7.  The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.

Authors:  Hans R Lüttichau
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

8.  Identification of G protein-coupled receptors for Drosophila PRXamide peptides, CCAP, corazonin, and AKH supports a theory of ligand-receptor coevolution.

Authors:  Yoonseong Park; Young-Joon Kim; Michael E Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptor.

Authors:  Melissa J S Chee; Karin Mörl; Diana Lindner; Nicole Merten; Gerald W Zamponi; Peter E Light; Annette G Beck-Sickinger; William F Colmers
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

10.  Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants.

Authors:  T Benned-Jensen; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2010-02-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.